Journal of Alzheimer's disease : JAD
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Latin dance and cognitive impairment: Importance of una Mezcla of culture and science..
-.
2024
-
The partner paradox: How can we better understand shared cognitive decline in couples?.
102:308-310.
2024
-
Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research..
99:S397-S407.
2024
-
Associations of Nativity and the Role of the Hispanic Paradox on the Cognitive Health of Older Latinos Living in the United States..
99:981-991.
2024
-
Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms..
100:1055-1073.
2024
-
Diagnoses and Treatment of Behavioral and Psychological Symptoms of Dementia Among Racially and Ethnically Diverse Persons Living with Dementia..
99:513-523.
2024
-
Dual-Language Use and Cognitive Function Among Mexican Americans Aged 65 and Older..
99:1105-1115.
2024
-
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging..
97:1689-1702.
2024
-
Optimizing the Implementation of a Lifestyle Dementia Prevention Intervention for Older Patients in an Academic Healthcare System..
100:1237-1259.
2024
-
The Use of Event Related Potentials to Predict Amyloid PET Status Among Patients from a Memory Disorders Clinic..
100:1195-1208.
2024
-
Unraveling the Threads: Sleep Difficulties, Neighborhood Physical Disorder, and Subjective Cognitive Decline in Older Americans..
100:1345-1354.
2024
-
What Matters to Chinese and Korean American Dementia Caregivers: Navigating Cultural Influences in Dementia Care from Caregivers' Perspectives..
98:519-538.
2024
-
A Qualitative Examination of Knowledge, Experiences, and Considerations of PET Brain Scan Participation Among Older Black and Latino Adults..
91:961-976.
2023
-
Acculturation in Context and Brain Health in Older Latino Adults: A Diffusion Tensor Imaging Study..
95:1585-1595.
2023
-
Association of MRI Visible Perivascular Spaces and Neurofilament Light Chain: The Framingham Heart Study..
95:1133-1145.
2023
-
Association of Physical Inactivity with MRI Markers of Brain Aging: Assessing Mediation by Cardiometabolic and Epigenetic Factors..
95:561-572.
2023
-
Associations Between Parity and Cognition: Race/Ethnic Differences..
94:1157-1168.
2023
-
Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings..
94:217-226.
2023
-
Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples..
92:109-128.
2023
-
Differences in the Cognitive Function of Mexican Adults Aged 60 and Older with Self-Reported Diabetes in 2001 and 2018..
95:1029-1039.
2023
-
Hospitalizations and Emergency Room Admissions by Mexican American Older Adults with and without Dementia and Caregiver Mental Health..
91:1185-1195.
2023
-
Let's Not Repeat History's Mistakes: Two Cautions to Scientists on the Use of Race in Alzheimer's Disease and Alzheimer's Disease Related Dementias Research..
92:729-740.
2023
-
Linking Air Pollution Exposure to Blood-Based Metabolic Features in a Community-Based Aging Cohort with and without Dementia..
96:1025-1040.
2023
-
MRI Visible Perivascular Spaces and the Risk of Incident Mild Cognitive Impairment in a Community Sample..
96:103-112.
2023
-
Pilot Study of Second-Generation DNA Methylation Epigenetic Markers in Relation to Cognitive and Neuropsychiatric Symptoms in Older Adults..
93:1563-1575.
2023
-
Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology..
95:735-748.
2023
-
Relationship Between Cognitive Performance, Physical Activity, and Socio-Demographic/Individual Characteristics Among Aging Americans..
92:975-987.
2023
-
Reliability and Validity of Self-Reported Vascular Risk Factors: Hypertension, Diabetes, and Heart Disease, in a Multi-Ethnic Community Based Study of Aging and Dementia..
95:275-285.
2023
-
Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study..
95:615-624.
2023
-
The Effect of Self-Reported Visual Impairment and Sleep on Cognitive Decline: Results of the Hispanic Community Health Study/Study of Latinos..
92:1257-1267.
2023
-
"Captive by the Uncertainty"-Experiences with Anticipatory Guidance for People Living with Dementia and Their Caregivers at a Specialty Dementia Clinic..
86:787-800.
2022
-
Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging..
86:53-65.
2022
-
Association of Carotid Intima Media Thickening with Future Brain Region Specific Amyloid-β Burden..
89:223-232.
2022
-
Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study..
86:1603-1609.
2022
-
Associations Between Midlife Functional Limitations and Self-Reported Health and Cognitive Status: Results from the 1998-2016 Health and Retirement Study..
85:1621-1637.
2022
-
Associations of Pulmonary Function with MRI Brain Volumes: A Coordinated Multi-Study Analysis..
90:1073-1083.
2022
-
Concordance Between Self-Reported Medical Diagnosis of Mild Cognitive Impairment/Dementia and Neurocognitive Function Among Middle-Aged and Older Hispanic/Latino Adults: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)..
88:45-55.
2022
-
Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults..
88:311-322.
2022
-
Lessons from Detecting Cognitive Impairment Including Dementia (DetectCID) in Primary Care..
86:655-665.
2022
-
Longitudinal Associations of Plasma TMAO and Related Metabolites with Cognitive Impairment and Dementia in Older Adults: The Cardiovascular Health Study..
89:1439-1452.
2022
-
Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study..
86:1371-1383.
2022
-
Olfactory Function and Markers of Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer's Disease..
88:721-729.
2022
-
Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics..
87:1229-1238.
2022
-
Undiagnosed Dementia Is Associated with Poor Physical Function in Older Adults..
89:473-482.
2022
-
Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study..
82:249-260.
2021
-
Central Obesity, Cardiometabolic Risk, and Cognitive Change in the Study of Latinos - Investigation of Neurocognitive Aging..
82:1203-1218.
2021
-
Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave..
81:679-690.
2021
-
Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II)..
84:1015-1028.
2021
-
Elevated Inflammatory Markers and Arterial Stiffening Exacerbate Tau but Not Amyloid Pathology in Older Adults with Mild Cognitive Impairment..
80:1451-1463.
2021
-
Herpes Labialis, Chlamydophila pneumoniae, Helicobacter pylori, and Cytomegalovirus Infections and Risk of Dementia: The Framingham Heart Study..
82:593-605.
2021
-
Improving Detection of Amnestic Mild Cognitive Impairment with Sex-Specific Cognitive Norms..
84:1763-1770.
2021
-
In Vivo Amyloid, Neurodegeneration, and Verbal Learning in Late Middle-Aged Hispanics..
82:317-325.
2021
-
Interleukin-6 Interacts with Sleep Apnea Severity when Predicting Incident Alzheimer's Disease Dementia..
79:1451-1457.
2021
-
Longitudinal Relationships Between Subjective Cognitive Decline and Objective Memory: Depressive Symptoms Mediate Between-Person Associations..
83:1623-1636.
2021
-
Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer's Disease Research..
80:927-940.
2021
-
Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease..
82:1809-1822.
2021
-
Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease..
80:1051-1065.
2021
-
Pre-Statistical Considerations for Harmonization of Cognitive Instruments: Harmonization of ARIC, CARDIA, CHS, FHS, MESA, and NOMAS..
83:1803-1813.
2021
-
Self-Reported Dementia-Related Diagnosis Underestimates the Prevalence of Older Americans Living with Possible Dementia..
82:373-380.
2021
-
Age of Migration and Cognitive Function Among Older Latinos in the United States..
76:1493-1511.
2020
-
Characterizing Clinical and Neuropathological Traits of APOE Haplotypes in African Americans and Europeans..
78:467-477.
2020
-
Cognition and Daily Functioning: Results from the Hispanic Community Health Study/Study of Latinos (SOL) and Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)..
77:1267-1278.
2020
-
Late-Life Physical and Cognitive Activities Independently Contribute to Brain and Cognitive Resilience..
74:363-376.
2020
-
Pre-Diabetes, but not Type 2 Diabetes, Is Related to Brain Amyloid in Late Middle-Age..
75:1241-1252.
2020
-
Pro-Neurotensin/Neuromedin N and Risk of Cognitive Impairment in a Prospective Study..
76:1403-1412.
2020
-
Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures..
78:1393-1408.
2020
-
Sex Differences in in vivo Alzheimer's Disease Neuropathology in Late Middle-Aged Hispanics..
74:1243-1252.
2020
-
Subjective Cognitive Decline Among Sexual and Gender Minorities: Results from a U.S. Population-Based Sample..
73:477-487.
2020
-
Dementia Risk Elevates Brain Activity During Memory Retrieval: A Functional MRI Analysis of Middle Aged and Older Adults..
70:1005-1023.
2019
-
Education Moderates the Relation Between APOE ɛ4 and Memory in Nondemented Non-Hispanic Black Older Adults..
72:495-506.
2019
-
Handgrip Strength Is Associated with Poorer Cognitive Functioning in Aging Americans..
70:1187-1196.
2019
-
Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts..
68:357-365.
2019
-
Tau13 Antibody Preferentially Immunoprecipitates High Molecular Weight Tau Proteins..
68:511-516.
2019
-
Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury..
68:187-196.
2019
-
Cognitively Healthy Individuals Want to Know Their Risk for Alzheimer's Disease: What Should We Do?.
62:499-502.
2018
-
Correlates of Subjective Cognitive Decline in Lesbian, Gay, Bisexual, and Transgender Older Adults..
64:91-102.
2018
-
Sex Influences the Accuracy of Subjective Memory Complaint Reporting in Older Adults..
61:1163-1178.
2018
-
Secular Trends in the Incidence of Dementia in a Multi-Ethnic Community..
60:1065-1075.
2017
-
Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health..
58:979-992.
2017
-
Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study..
59:975-985.
2017
-
Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer's Disease Pathology in Women versus Men?.
56:947-957.
2017
-
Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients..
60:43-56.
2017
-
Physical Activity in Midlife is not Associated with Cognitive Health in Later Life Among Cognitively Normal Older Adults..
59:1349-1358.
2017
-
Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology..
53:1553-62.
2016
-
Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease..
53:921-32.
2016
-
Non-Fibrillar Oligomeric Amyloid-β within Synapses..
53:787-800.
2016
-
Dementia Risk and Protective Factors Differ in the Context of Memory Trajectory Groups..
52:1013-20.
2016
-
Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study..
51:451-61.
2016
-
Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial..
51:501-14.
2016
-
Self-Reported Change in Quality of Life with Retirement and Later Cognitive Decline: Prospective Data from the Nurses' Health Study..
52:887-98.
2016
-
Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes..
44:937-47.
2015
-
Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults..
46:63-73.
2015
-
Midlife Hypertension Risk and Cognition in the Non-Demented Oldest Old: Framingham Heart Study..
47:197-204.
2015
-
Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease..
47:955-64.
2015
-
The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment..
47:421-32.
2015
-
Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum..
41:719-28.
2014
-
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum..
42:291-300.
2014
-
Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele..
37:421-8.
2013
-
Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals..
33 Suppl 1:S417-26.
2013
-
Frequency and clinicopathological characteristics of presenilin 1 Gly206Ala mutation in Puerto Rican Hispanics with dementia..
33:1089-95.
2013
-
Risk estimations, risk factors, and genetic variants associated with Alzheimer's disease in selected publications from the Framingham Heart Study..
33 Suppl 1:S439-45.
2013
-
Association of HSP70 and its co-chaperones with Alzheimer's disease..
25:93-102.
2011
-
Performance characteristics of plasma amyloid-beta 40 and 42 assays..
16:277-85.
2009
-
Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease?.
9:393-8.
2006
-
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease..
1:119-134.
1998
Identity
International Standard Serial Number (ISSN)